316 related articles for article (PubMed ID: 32711376)
1. Chemokines in bone-metastatic breast cancer: Therapeutic opportunities.
Wang Y; Ren S; Wang Z; Wang Z; Zhu N; Cai D; Ye Z; Ruan J
Int Immunopharmacol; 2020 Oct; 87():106815. PubMed ID: 32711376
[TBL] [Abstract][Full Text] [Related]
2. The multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers.
Midavaine É; Côté J; Sarret P
Cancer Metastasis Rev; 2021 Jun; 40(2):427-445. PubMed ID: 33973098
[TBL] [Abstract][Full Text] [Related]
3. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity.
Saxena S; Singh RK
Cancer Metastasis Rev; 2021 Jun; 40(2):447-476. PubMed ID: 33959849
[TBL] [Abstract][Full Text] [Related]
4. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
[TBL] [Abstract][Full Text] [Related]
5. The role of chemokines in the biology and therapy of breast cancer.
Walser TC; Fulton AM
Breast Dis; 2004; 20():137-43. PubMed ID: 15687714
[TBL] [Abstract][Full Text] [Related]
6. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy.
Bule P; Aguiar SI; Aires-Da-Silva F; Dias JNR
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575965
[TBL] [Abstract][Full Text] [Related]
7. The Complexity of Targeting Chemokines to Promote a Tumor Immune Response.
Strazza M; Mor A
Inflammation; 2020 Aug; 43(4):1201-1208. PubMed ID: 32314127
[TBL] [Abstract][Full Text] [Related]
8. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.
Nagarsheth N; Wicha MS; Zou W
Nat Rev Immunol; 2017 Sep; 17(9):559-572. PubMed ID: 28555670
[TBL] [Abstract][Full Text] [Related]
9. Chemokines and breast cancer: a gateway to revolutionary targeted cancer treatments?
Dowsland MH; Harvey JR; Lennard TW; Kirby JA; Ali S
Curr Med Chem; 2003 Apr; 10(7):579-92. PubMed ID: 12678790
[TBL] [Abstract][Full Text] [Related]
10. Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis.
Monteran L; Ershaid N; Sabah I; Fahoum I; Zait Y; Shani O; Cohen N; Eldar-Boock A; Satchi-Fainaro R; Erez N
Sci Rep; 2020 Aug; 10(1):13838. PubMed ID: 32796899
[TBL] [Abstract][Full Text] [Related]
11. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
Morein D; Erlichman N; Ben-Baruch A
Front Immunol; 2020; 11():952. PubMed ID: 32582148
[TBL] [Abstract][Full Text] [Related]
12. The role of chemokines in breast cancer pathology and its possible use as therapeutic targets.
Palacios-Arreola MI; Nava-Castro KE; Castro JI; García-Zepeda E; Carrero JC; Morales-Montor J
J Immunol Res; 2014; 2014():849720. PubMed ID: 25165728
[TBL] [Abstract][Full Text] [Related]
13. Chemokines and chemokine receptors: A new strategy for breast cancer therapy.
Liu H; Yang Z; Lu W; Chen Z; Chen L; Han S; Wu X; Cai T; Cai Y
Cancer Med; 2020 Jun; 9(11):3786-3799. PubMed ID: 32253815
[TBL] [Abstract][Full Text] [Related]
14. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
[TBL] [Abstract][Full Text] [Related]
15. Advancing Immunotherapy in Metastatic Breast Cancer.
Mansour M; Teo ZL; Luen SJ; Loi S
Curr Treat Options Oncol; 2017 Jun; 18(6):35. PubMed ID: 28534250
[TBL] [Abstract][Full Text] [Related]
16. Immune Modulation of Metastatic Niche Formation in the Bone.
Cheng X; Wang Z
Front Immunol; 2021; 12():765994. PubMed ID: 34745140
[TBL] [Abstract][Full Text] [Related]
17. Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy.
Vilgelm AE; Richmond A
Front Immunol; 2019; 10():333. PubMed ID: 30873179
[TBL] [Abstract][Full Text] [Related]
18. Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis.
Kähkönen TE; Halleen JM; Bernoulli J
Cells; 2021 Jun; 10(6):. PubMed ID: 34204474
[TBL] [Abstract][Full Text] [Related]
19. ERRα Expression in Bone Metastases Leads to an Exacerbated Antitumor Immune Response.
Bouchet M; Lainé A; Boyault C; Proponnet-Guerault M; Meugnier E; Bouazza L; Kan CWS; Geraci S; El-Moghrabi S; Hernandez-Vargas H; Benetollo C; Yoshiko Y; Duterque-Coquillaud M; Clézardin P; Marie JC; Bonnelye E
Cancer Res; 2020 Jul; 80(13):2914-2926. PubMed ID: 32366476
[TBL] [Abstract][Full Text] [Related]
20. Chemokines: novel targets for breast cancer metastasis.
Ali S; Lazennec G
Cancer Metastasis Rev; 2007 Dec; 26(3-4):401-20. PubMed ID: 17717637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
